Junyuan Jerry Wang

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
New York, NY
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Ron A. Metzger, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Junyuan Jerry Wang

Form 4 holding CEO, ANHEART THERAPEUTICS LTD., Director

Nuvation Bio Inc.

Security class
Class A Common Stock
Shares / value
3,866,228
Estimated value
$11,173,399
Report date
11 Nov 2024
Price
$2.89
Ownership
Direct
Form 4 holding CEO, ANHEART THERAPEUTICS LTD., Director

Nuvation Bio Inc.

Security class
Class A Common Stock
Shares / value
2,246,458
Estimated value
$6,492,264
Report date
11 Nov 2024
Price
$2.89
Ownership
By LLC
Form 4 holding CEO, ANHEART THERAPEUTICS LTD., Director

Nuvation Bio Inc.

Security class
Stock Option (Right to Buy)
Shares / value
388,299
Estimated value
Report date
09 Apr 2024
Price
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
Form 4 holding CEO, ANHEART THERAPEUTICS LTD., Director

Nuvation Bio Inc.

Security class
Warrants (Right to Buy)
Shares / value
86,471
Estimated value
Report date
03 Sep 2024
Price
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
Form 4 holding CEO, ANHEART THERAPEUTICS LTD., Director

Nuvation Bio Inc.

Security class
Warrants (Right to Buy)
Shares / value
57,647
Estimated value
Report date
03 Sep 2024
Price
Ownership
By LLC
Underlying class
Class A Common Stock
Underlying amount
Form 4 holding CEO, ANHEART THERAPEUTICS LTD., Director

Nuvation Bio Inc.

Security class
Series A Preferred Stock
Shares / value
0
Estimated value
Report date
04 Sep 2024
Price
Ownership
By LLC
Underlying class
Class A Common Stock
Underlying amount
Form 4 holding CEO, ANHEART THERAPEUTICS LTD., Director

Nuvation Bio Inc.

Security class
Series A Preferred Stock
Shares / value
0
Estimated value
Report date
04 Sep 2024
Price
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount

Insider Reports Filed by Junyuan Jerry Wang

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .